The program will improve access to adeno-associated virus gene therapy vectors. On Oct. 10, 2023, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results